Zacks Investment Research
03 Mar 2026, 18:00 UTC · 34w ago
Verdict
Headline takes no side. We score KIDS +1.00 across two claims — strongly bullish.
+1.00strongly bullish
More positive than 99% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
What the story claims
2 claims · scored −1 bearish … +1 bullish
OrthoPediatrics (KIDS) has been upgraded to a Zacks Rank #2 (Buy).
So whatA rating upgrade based on positive earnings estimate revisions typically signals buying pressure and potential near-term price appreciation for the specific ticker.
More positive than 77% of claims this week
The upgrade for OrthoPediatrics reflects an upward trend in the company's earnings estimates.
So whatPositive revisions to the Zacks Consensus Estimate suggest an improvement in the underlying business fundamentals, which is a primary driver for institutional buying.
Continue reading
5 related stories
More positive than 64% of claims this week
Which stocks this story touches
More positive than 99% of ticker scores this week
The company was upgraded to a Zacks Rank #2 (Buy) due to an upward trend in earnings estimates.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The Motley Fool
41m ago
+23.9%
Price agrees with the score
$23.82 vs $19.22 close before publication (Mar 2) · not market-adjusted
KIDS chart →
